February 13, 2023
Japanese regulatory authorities have approved a shelf-life extension for Pfizer’s oral COVID-19 treatment Paxlovid (nirmatrelvir/ritonavir) from 18 months to 24 months. The shelf-life of the drug was originally 12 months upon its special approval in February 2022. It was extended...read more